1.	Development and Evaluation of a Cancer-Related Fatigue Patient Education Program Phase: No phase specified Type: Educational/Counseling/Training, Supportive care Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 41100133, NCT00552552
2.	Reduction of Cancer Related Fatigue in Patients With Renal Cell Carcinoma Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: S-154/2012, NCT01645150
3.	The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory Pilot Study Phase: No phase specified Type: Supportive care Status: Active Age: 7 to 21 Sponsor: NIMH Protocol IDs: 090022, 09-M-0022, NCT00824278
4.	Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000727326, RTOG-1115, NCT01546987
5.	Study of Red Bull™ Sugar-Free Drink for Reduction of Fatigue in Prostate Cancer Patients Receiving LHRH Agonist Therapy Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: 12-5041-C, NCT01669460
6.	Multimodal Therapy for Sleep Disturbances Phase: Phase II Type: Supportive care Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 2012-0120, NCT01628029
7.	Study of Nonpharmacological Management of Respiratory Distress Symptom Cluster Performed by Patients' Caregivers in Patients With Lung Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: No phase specified Type: Health services research, Supportive care Status: Active Age: Not specified Sponsor: Other Protocol IDs: UM-LC-Symptom-Clusters, UM-LC-Symptom Clusters, EU-20972, NCT00979888
8.	Exercise During the Allogeneic Stem Cell Transplantation Phase: Phase III Type: Supportive care Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: EA4/030/09, NCT00883714
9.	Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000686072, RTOG-1008, NCT01220583
10.	Individualized Nutrition for Adult Recipients of Allogeneic Stem Cell Transplants - Effect on Quality of Life Phase: No phase specified Type: Supportive care Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: S-09136c, NCT01181076
11.	Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Germanium, NCT00651417
12.	Fatigue Before and After Exercise in Patients With Advanced Cancer Stage Phase: No phase specified Type: Supportive care Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: fatigue-hcb-01, NCT01581216
13.	Exercise in Lessening Fatigue Caused by Cancer in Patients Undergoing Chemotherapy Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 21 and over Sponsor: NCI, Other Protocol IDs: UCCO08106; URCC0701, U10CA037420, UCCO-08106, URCC 0701, URCC-O08106, NCT00924651
14.	Acupressure for Persistent Cancer Related Fatigue Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 to 75 Sponsor: NCI, Other Protocol IDs: CA151445, R01CA151445, NCT01281904
15.	Treatment of Depressive Symptoms in Cancer Patients: Comparison of Light Therapy and Cognitive Therapy Phase: No phase specified Type: Supportive care Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: H10-12-123, NCT01637103
16.	Exercise for Patients With Renal Cell Cancer Receiving Sunitinib Phase: Phase III Type: Supportive care Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: SUIR8687, NCT00869011
17.	Investigating Molecular-Genetic Correlates of Fatigue Experienced by Cancer Patients Receiving Treatment Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: NINR Protocol IDs: 110014, 11-NR-0014, NCT01231932
18.	An Investigation of Light Therapy for Cancer-related Fatigue (The LITE Study) Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: 10003569, NCT01780623
19.	Multimodal Therapy for Treatment of Fatigue Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2011-0389, NCT01410942
20.	Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission Phase: Phase I Type: Biomarker/Laboratory analysis, Natural history/Epidemiology Status: Active Age: 1 to 20 Sponsor: NCI, Other Protocol IDs: CDR0000624471, VU-VICC-PED-0872, IRB# 081043, VICCPED0872, NCT00801346
21.	Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 15 to 39 Sponsor: Other Protocol IDs: 091550, NCT01228461
22.	PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care Phase: Phase IV Type: Supportive care Status: Active Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PH-CP012 (II), NCT01720550
23.	A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 07-341, NCT00766467
24.	Armodafinil in Reducing Cancer-Related Fatigue in Patients With Glioblastoma Multiforme Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: A221101, N10C3, NCI-2012-02020, NCT01781468
25.	Adapted Physical Activity Effect and Fatigue in Patients With Breast Cancer Phase: No phase specified Type: Supportive care Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: I10 009 / SAPA, NCT01322412